This review focusses on the erythrocytes (RBCs) and their structural changes during inflammation and impaired blood rheology. We discuss systemic inflammation and the effects of dysregulated inflammatory molecules. These pro-inflammatory molecules directly affect the haematological system, and particularly the RBCs, platelets and plasma proteins. We focus on the three main changes; increased RBC eryptosis (programmed cell death, similar to apoptosis) and pathological deformability, platelet hyperreactivity and anomalous blood clotting, due to pathological changes to fibrin(ogen) protein structure. This pro-inflammatory haematological system directly affects blood rheology. In turn, hemorheological parameters such as RBC deformability are important parameters in hypercoagulation, which is a hallmark of inflammation. For RBC deformation to happen during blood flow, the RBC membrane needs to be elastic to elongate sufficiently to squeeze through small capillaries. However, of greater importance is that the cell must return to its original biconcave shape after exiting the small diameter capillaries.
CONCLUSION:
Hemorheological parameters such as RBC deformability are of great importance clinically, to both identify the presence and extent of inflammation, and to study these parameters during intervention therapies. RBC rheology and deformability may therefore be a useful cell model for pharmaceutical testing.
ButtariB, ProfumoE. Crosstalk between red blood cells and the immune system and its impact on atherosclerosis. BioMed Research International. 2015;2015:616834.
2.
ChuAJ. Role of tissue factor in thrombosis. Coagulation-inflammation-thrombosis circuit. Front Biosci. 2006;11, 256–71.
3.
NurdenAT. Platelets, inflammation and tissue regeneration. Thromb Haemost. 2011;105(Suppl 1):S13–33.
4.
BesterJ, PretoriusE. Effects of IL-1β, IL-6 and IL-8 on erythrocytes, platelets and clot viscoelasticity. Scientific Reports. 2016;6, 32188.
PretoriusE. The adaptability of red blood cells. Cardiovasc Diabetol. 2013;12, 63.
7.
PretoriusE, du PlooyJN, BesterJ. A Comprehensive Review on Eryptosis. Cell Physiol Biochem. 2016;39(5):1977–2000.
8.
SomaP, SwanepoelAC, du PlooyJN, MqocoT, PretoriusE. Flow cytometric analysis of platelets type 2 diabetes mellitus reveals ‘angry’ platelets. Cardiovasc Diabetol. 2016;15(1):52.
9.
ChuAJ. Tissue factor upregulation drives a thrombosis-inflammation circuit in relation to cardiovascular complications. Cell Biochem Funct. 2006;24(2):173–92.
10.
DávalosD, AkassoglouK. Fibrinogen as a key regulator of inflammation in disease. Semin Immunopathol. 2012;34(1):43–62.
11.
KarpmanD, StåhlAL, ArvidssonI, JohanssonK, LoosS, TatiR, et al. Complement Interactions with Blood Cells, Endothelial Cells and Microvesicles in Thrombotic and Inflammatory Conditions. Adv Exp Med Biol. 2015;865, 19–42.
12.
AlemanMM, WaltonBL, ByrnesJR, WolbergAS. Fibrinogen and red blood cells in venous thrombosis. Thromb Res.S. 2014;133(Suppl 1):38–40.
QadriSM, MahmudH, LangE, GuS, BobbalaD, ZelenakC, et al. Enhanced suicidal erythrocyte death in mice carrying a loss-of-function mutation of the adenomatous polyposis coli gene. J Cell Mol Med. 2012;16(5):1085–93.
21.
PretoriusE, Olumuyiwa-AkeredoluOO, MbotweS, BesterJ. Erythrocytes and their role as health indicator: Using structure in a patient-orientated precision medicine approach. Blood Rev. 2016;30(4):263–74.
22.
RanQ, XiangY, LiuY, XiangL, LiF, DengX, et al. Eryptosis Indices as a Novel Predictive Parameter for Biocompatibility of Fe3O4 Magnetic Nanoparticles on Erythrocytes. Sci Re. 2015;5, 16209.
23.
BorstO, AbedM, AlesutanI, TowhidST, QadriSM, FollerM, et al. Dynamic adhesion of eryptotic erythrocytes to endothelial cells via CXCL16/SR-PSOX. Am J Physiol Cell Physiol. 2012;302(4):C644–51.
24.
GasparyanAY, AyvazyanL, PretoriusE, KitasGD. Platelets in rheumatic diseases: Friend or foe?Curr Pharm Des (2014;20(4):552–66.
25.
PretoriusE. The role of platelet and fibrin ultrastructure in identifying disease patterns. Pathophysiol Haemost Thromb. 2008;36(5):251–8.
26.
van RooyM, PretoriusE. Metabolic syndrome, platelet activation and the development of transient ischemic attack or thromboembolic stroke. Thromb Res. 2015;135(3):434–42.
27.
van RooyMJ, DuimW, EhlersR, BuysAV, PretoriusE. Platelet hyperactivity and fibrin clot structure in transient ischemic attack individuals in the presence of metabolic syndrome: A microscopy and thromboelastography study. Cardiovasc Diabetol. 2015;14, 86.
28.
KellDB, PretoriusE. Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells. Metallomics. 2014;6(4):748–73.
29.
KellDB, PretoriusE. The simultaneous occurrence of both hypercoagulability and hypofibrinolysis in blood and serum during systemic inflammation, and the roles of iron and fibrin(ogen). Integrative Biology. 2015;7, 24–52.
30.
KellDB, PretoriusE. Proteins behaving badly. Substoichiometric molecular control and amplification of the initiation and nature of amyloid fibril formation: Lessons from and for blood clotting. Prog Biophys Mol Biol. 2017;123, 16–41.
PretoriusE, MbotweS, BesterJ, RobinsonCJ, KellDB. Acute induction of anomalous and amyloidogenic blood clotting by molecular amplification of highly substoichiometric levels of bacterial lipopolysaccharide. J R Soc Interface. 13(122). 2016).
33.
PretoriusE, SwanepoelAC, BuysAV, VermeulenN, DuimW, KellDB. Eryptosis as a marker of Parkinson’s disease. Aging-US. 2014;6, 788–818.
34.
PretoriusE, BesterJ, VermeulenN, LipinskiB, GerickeGS, KellDB. Profound morphological changes in the erythrocytes and fibrin networks of patients with hemochromatosis or with hyperferritinemia, and their normalization by iron chelators and other agents. PLoS One. 2014; doi:10.1371/journal.pone.0085271 eCollection 2014.
35.
BesterJ, BuysAV, LipinskiB, KellDB, PretoriusE. High ferritin levels have major effects on the morphology of erythrocytes in Alzheimer’s disease. Front Aging Neurosci. 2013;5, 88.
36.
BesterJ, SomaP, KellDB, PretoriusE. Viscoelastic and ultrastructural characteristics of whole blood and plasma in Alzheimer-type dementia, and the possible role of bacterial lipopolysaccharides (LPS). Oncotarget. 2015;6, 35284–303.
37.
PretoriusE, AkeredoluOO, SomaP, KellDB. Major involvement of bacterial components in rheumatoid arthritis and its accompanying oxidative stress, systemic inflammation and hypercoagulability. Exp Biol Med (Maywood). 2017;242(4):355–73.
38.
PretoriusE, BesterJ, VermeulenN, AlummoottilS, SomaP, BuysAV, et al. Poorly controlled type 2 diabetes is accompanied by significant morphological and ultrastructural changes in both erythrocytes and in thrombin-generated fibrin: Implications for diagnosticsCardiovasc Diabetol. 2015;14, 30.
